EP300 and prostate sarcoma: In addition, an adult embryonic RMS of the prostate reported recently by Olivas and Antic [17] had point mutation of ARID1A plus mutations in KRAS, PIK3CA, and EP300. These data suggest that ARID1A mutations may not be non-recurrent genetic events in high-grade prostatic sarcomas.